P Rajagopalan to Recombinant Fusion Proteins
This is a "connection" page, showing publications P Rajagopalan has written about Recombinant Fusion Proteins.
Connection Strength
0.045
-
Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group. Transplantation. 1999 Nov 15; 68(9):1288-94.
Score: 0.037
-
Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation. 1999 Jan 27; 67(2):276-84.
Score: 0.009